United States
Germany
Japan
United Kingdom
China
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Antibodies
CNY 3,990.00
2周
CNY 3,990.00
2周
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Rabbit Polyclonal ERK1/2 (Thr202/Tyr204) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
Rabbit Polyclonal ERK1/2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
ERK1 (MAPK3) (+ERK2) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
ERK1 (MAPK3) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Conjugates
Modifications
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (21)
- Adherens junction (21)
- Alzheimer's disease (21)
- Axon guidance (21)
- B cell receptor signaling pathway (21)
- Bladder cancer (21)
- Chemokine signaling pathway (21)
- Chronic myeloid leukemia (21)
- Colorectal cancer (21)
- Dorso-ventral axis formation (21)
- Endometrial cancer (21)
- ErbB signaling pathway (21)
- Fc epsilon RI signaling pathway (21)
- Fc gamma R-mediated phagocytosis (21)
- Focal adhesion (21)
- Gap junction (21)
- Glioma (21)
- GnRH signaling pathway (21)
- Insulin signaling pathway (21)
- Long-term depression (21)
- Long-term potentiation (21)
- MAPK signaling pathway (21)
- Melanogenesis (21)
- Melanoma (21)
- NOD-like receptor signaling pathway (21)
- Natural killer cell mediated cytotoxicity (21)
- Neurotrophin signaling pathway (21)
- Non-small cell lung cancer (21)
- Oocyte meiosis (21)
- Pancreatic cancer (21)
- Pathways in cancer (21)
- Prion diseases (21)
- Progesterone-mediated oocyte maturation (21)
- Prostate cancer (21)
- Regulation of actin cytoskeleton (21)
- Renal cell carcinoma (21)
- T cell receptor signaling pathway (21)
- TGF-beta signaling pathway (21)
- Thyroid cancer (21)
- Toll-like receptor signaling pathway (21)
- Type II diabetes mellitus (21)
- VEGF signaling pathway (21)
- Vascular smooth muscle contraction (21)
- mTOR signaling pathway (21)
